Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
April 10, 2019
Male age is associated with sperm DNA/chromatin integrity
Anupama Deenadayal Mettler, Mirudhubashini Govindarajan, Sapna Srinivas, et al.
Clinical and Experimental Reproductive Medicine
|
November 23, 2020
Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure
Vidya Laxme B, Silviya Stephen, Ramyashree Devaraj, et al.
Cancers
|
July 3, 2019
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients
Sridurga Mithraprabhu, Jay Hocking, Malarmathy Ramachandran, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 9, 2021
Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma
Antonia Reale, Tiffany Khong, Rong Xu, et al.
Biology of Reproduction
|
February 5, 2010
Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo
Sridurga Mithraprabhu, Sirisha Mendis, Sarah J Meachem, et al.
Cancers
|
February 15, 2022
Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
Ioanna Savvidou, Tiffany Khong, Sophie Whish, et al.
Blood Advances
|
January 15, 2026
A biomarker risk assessment tool predicts infection-related mortality after allogeneic stem cell transplantation
Joanne Lay Cheng Tan, Tiffany Khong, Yu Jin Kim, et al.
British Journal of Haematology
|
September 18, 2020
Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma
Sridurga Mithraprabhu, Anna Kalff, Kate H Gartlan, et al.
Leukemia & Lymphoma
|
June 12, 2019
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)
Anna Kalff, Tiffany Khong, Sridurga Mithraprabhu, et al.
Leukemia & Lymphoma
|
November 2, 2020
TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing
Antonia Reale, Tiffany Khong, Sridurga Mithraprabhu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
April 10, 2019
Male age is associated with sperm DNA/chromatin integrity
Anupama Deenadayal Mettler, Mirudhubashini Govindarajan, Sapna Srinivas, et al.
Clinical and Experimental Reproductive Medicine
|
November 23, 2020
Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure
Vidya Laxme B, Silviya Stephen, Ramyashree Devaraj, et al.
Cancers
|
July 3, 2019
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients
Sridurga Mithraprabhu, Jay Hocking, Malarmathy Ramachandran, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 9, 2021
Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma
Antonia Reale, Tiffany Khong, Rong Xu, et al.
Biology of Reproduction
|
February 5, 2010
Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo
Sridurga Mithraprabhu, Sirisha Mendis, Sarah J Meachem, et al.
Cancers
|
February 15, 2022
Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
Ioanna Savvidou, Tiffany Khong, Sophie Whish, et al.
Blood Advances
|
January 15, 2026
A biomarker risk assessment tool predicts infection-related mortality after allogeneic stem cell transplantation
Joanne Lay Cheng Tan, Tiffany Khong, Yu Jin Kim, et al.
British Journal of Haematology
|
September 18, 2020
Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma
Sridurga Mithraprabhu, Anna Kalff, Kate H Gartlan, et al.
Leukemia & Lymphoma
|
June 12, 2019
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)
Anna Kalff, Tiffany Khong, Sridurga Mithraprabhu, et al.
Leukemia & Lymphoma
|
November 2, 2020
TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing
Antonia Reale, Tiffany Khong, Sridurga Mithraprabhu, et al.
Page
of 3